Ralliant (NYSE:RAL) Issues FY 2026 Earnings Guidance

Ralliant (NYSE:RAL) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 2.220-2.420 for the period, compared to the consensus estimate of 2.710. The company issued revenue guidance of $2.1 billion-$2.2 billion, compared to the consensus revenue estimate of $2.1 billion. Ralliant also updated its Q1 2026 guidance to 0.460-0.520 EPS.

Wall Street Analyst Weigh In

A number of brokerages recently commented on RAL. Oppenheimer upped their price objective on Ralliant from $55.00 to $60.00 and gave the stock an “outperform” rating in a research note on Monday, December 15th. Royal Bank Of Canada upped their price target on shares of Ralliant from $45.00 to $52.00 and gave the stock a “sector perform” rating in a research report on Friday, November 7th. Weiss Ratings reissued a “hold (c)” rating on shares of Ralliant in a research note on Monday, December 29th. Barclays raised their price target on shares of Ralliant from $59.00 to $60.00 and gave the company an “overweight” rating in a research note on Wednesday, January 7th. Finally, Truist Financial started coverage on Ralliant in a report on Friday, December 12th. They set a “buy” rating and a $62.00 price target on the stock. Six research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $58.00.

Ralliant Price Performance

Shares of NYSE:RAL traded up $1.38 during trading on Wednesday, reaching $56.11. The company had a trading volume of 2,847,355 shares, compared to its average volume of 1,384,394. The firm’s fifty day moving average is $51.92 and its 200 day moving average is $46.83. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.03 and a current ratio of 1.49. The firm has a market capitalization of $6.33 billion and a PE ratio of 44.18. Ralliant has a twelve month low of $40.70 and a twelve month high of $57.02.

Ralliant (NYSE:RAL) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $0.69 EPS for the quarter, beating analysts’ consensus estimates of $0.67 by $0.02. The company’s revenue for the quarter was up 1.2% on a year-over-year basis. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 23rd. Investors of record on Monday, March 9th will be paid a dividend of $0.05 per share. The ex-dividend date of this dividend is Monday, March 9th. This represents a $0.20 annualized dividend and a yield of 0.4%. Ralliant’s dividend payout ratio (DPR) is currently 15.75%.

Key Ralliant News

Here are the key news stories impacting Ralliant this week:

• Positive Sentiment: Q1 revenue guidance topped Street expectations — Ralliant guided Q1‑2026 revenue to $508M–$522M versus a $501.8M consensus, which supports the view of continued sales growth into the new year. Ralliant Reports Fourth Quarter and Full Year 2025 Results
• Neutral Sentiment: FY‑2026 revenue guide was in line with consensus at $2.1B–$2.2B, so top‑line expectations are roughly confirmed even as profitability guidance diverges from estimates. Ralliant Reports Fourth Quarter and Full Year 2025 Results
• Negative Sentiment: FY‑2026 EPS guidance of $2.220–$2.420 came in below the $2.71 consensus, a downside surprise for earnings estimates that likely tempers upside. Ralliant Corporation Posts Q4 Results and Issues 2026 Outlook
• Negative Sentiment: Q1‑2026 EPS guide of $0.460–$0.520 also missed the $0.53 consensus, signaling the company expects a more gradual earnings recovery. Ralliant Corporation Posts Q4 Results and Issues 2026 Outlook
• Negative Sentiment: Q4 GAAP loss was sharply negative: Ralliant reported a $1.4B net loss (‑$12.10 per share) driven by a $1.4B non‑cash goodwill impairment in its Test & Measurement segment — a one‑time charge that explains the EPS miss but raises near‑term headline volatility. Press Release (PDF)

Hedge Funds Weigh In On Ralliant

Several hedge funds have recently made changes to their positions in RAL. CIBC Bancorp USA Inc. bought a new stake in shares of Ralliant in the 3rd quarter worth approximately $403,000. Wilmington Savings Fund Society FSB acquired a new position in Ralliant in the third quarter worth approximately $30,000. Advisory Services Network LLC bought a new position in shares of Ralliant in the third quarter valued at $82,000. Livforsakringsbolaget Skandia Omsesidigt increased its holdings in shares of Ralliant by 990.0% in the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 7,423 shares of the company’s stock valued at $325,000 after buying an additional 6,742 shares in the last quarter. Finally, Keystone Financial Group acquired a new stake in shares of Ralliant during the 3rd quarter valued at $306,000.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.